In October, the People’s Republic of China celebrates its annual national holiday, known as Golden Week. Similar to Chinese New Year, the entire country is on holiday, resulting in business closures and a potential 14-day halt in production and transportation of manufactured goods.
In addition, most of the 35 affected chemicals will also require explicit consent from the importing country before exports can take place. Four that were previously subject only to export notification will now also require explicit consent. The IT tool ePIC has been updated accordingly and companies can already start notifying their exports.
Planning Ahead Is Half The Battle
To avoid unnecessary supply chain disruptions during China’s Golden Week, a good advance planning strategy is essential, including:
Logistics and transportation:
To ensure customer satisfaction during the busy period leading up to Golden Week, it is critical to plan transportation capacity and work with reliable partners to avoid potential delays and bottlenecks in logistics services.
Warehousing and inventory management:
Especially in light of the upcoming holidays, companies should adopt inventory optimization strategies to position the right inventory of the right goods at different nodes in the supply chain to keep products closer to actual demand, which requires, above all, flexible and good warehousing and inventory management.
Reference:
Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.
N,N′-Dimethylethylenediamine (DMEDA) is an organic chemical compound belonging to the diamine family. It contains two nitrogen atoms, each bearing a methyl group, connected by a two-carbon chain.
Global shipping costs have climbed to $4,000–$4,500 in October from $2,000–$2,500 in February 2026. Freight rates, which had eased through much of 2025 and early 2026 as the demand-supply balance improved, have rebounded sharply in recent months. The increase has brought shipping costs back into focus for businesses dependent on international cargo movement.
The U.S. Food and Drug Administration (FDA) has finalized guidance outlining how manufacturers should report post-approval manufacturing changes for biosimilar and interchangeable biosimilar products. The guidance provides greater regulatory clarity on changes involving production processes, manufacturing sites, analytical methods, raw materials, and process controls. It aims to ensure product quality while reducing unnecessary regulatory burden.